Multi-Target Effects of the Cannabinoid CP55940 on Familial Alzheimer's Disease PSEN1 E280A Cholinergic-Like Neurons: Role of CB1 Receptor

Overview

Journal J Alzheimers Dis

Publisher Sage Publications

Specialties Geriatrics
Neurology

Date 2020 Nov 30

PMID 33252082

Citations 9

Authors

Viviana Soto-Mercado

Miguel Mendivil-Perez

Marlene Jimenez-Del-Rio

Carlos Velez-Pardo

Affiliations

Soon will be listed here.

Abstract

Background: Alzheimer's disease (AD) is characterized by structural damage, death, and functional disruption of cholinergic neurons (ChNs) as a result of intracellular amyloid-β (Aβ) aggregation, extracellular neuritic plaques, and hyperphosphorylation of protein tau (p-Tau) overtime.

Objective: To evaluate the effect of the synthetic cannabinoid CP55940 (CP) on PSEN1 E280A cholinergic-like nerve cells (PSEN1 ChLNs)-a natural model of familial AD.

Methods: Wild type (WT) and PSEN1 ChLNs were exposed to CP (1μM) only or in the presence of the CB1 and CB2 receptors (CB1Rs, CB2Rs) inverse agonist SR141716 (1μM) and SR144528 (1μM) respectively, for 24 h. Untreated or treated neurons were assessed for biochemical and functional analysis.

Results: CP in the presence of both inverse agonists (hereafter SR) almost completely inhibits the aggregation of intracellular sAβPPβf and p-Tau, increases ΔΨm, decreases oxidation of DJ-1Cys106-SH residue, and blocks the activation of c-Jun, p53, PUMA, and caspase-3 independently of CB1Rs signaling in mutant ChLNs. CP also inhibits the generation of reactive oxygen species partially dependent on CB1Rs. Although CP reduced extracellular Aβ42, it was unable to reverse the Ca2+ influx dysregulation as a response to acetylcholine stimuli in mutant ChLNs. Exposure to anti-Aβ antibody 6E10 (1:300) in the absence or presence of SR plus CP completely recovered transient [Ca2+]i signal as a response to acetylcholine in mutant ChLNs.

Conclusion: Taken together our findings suggest that the combination of cannabinoids, CB1Rs inverse agonists, and anti-Aβ antibodies might be a promising therapeutic approach for the treatment of familial AD.

Citing Articles

A Comprehensive Exploration of the Multifaceted Neuroprotective Role of Cannabinoids in Alzheimer's Disease across a Decade of Research.

Tyrakis P, Agridi C, Kourti M Int J Mol Sci. 2024; 25(16).

PMID: 39201317 PMC: 11354546. DOI: 10.3390/ijms25168630.

Neuroprotective Effects of Cannabispirenone A against NMDA-Induced Excitotoxicity in Differentiated N2a Cells.

Thapa S, Nalli Y, Singh A, Singh S, Ali A Oxid Med Cell Longev. 2024; 2024:3530499.

PMID: 38855429 PMC: 11161259. DOI: 10.1155/2024/3530499.

Combination of Tramiprosate, Curcumin, and SP600125 Reduces the Neuropathological Phenotype in Familial Alzheimer Disease PSEN1 I416T Cholinergic-like Neurons.

Gomez-Sequeda N, Jimenez-Del-Rio M, Velez-Pardo C Int J Mol Sci. 2024; 25(9).

PMID: 38732141 PMC: 11084854. DOI: 10.3390/ijms25094925.

PSEN1 E280A Cholinergic-like Neurons and Cerebral Spheroids Derived from Mesenchymal Stromal Cells and from Induced Pluripotent Stem Cells Are Neuropathologically Equivalent.

Mendivil-Perez M, Velez-Pardo C, Lopera F, Kosik K, Jimenez-Del-Rio M Int J Mol Sci. 2023; 24(10).

PMID: 37240306 PMC: 10218810. DOI: 10.3390/ijms24108957.

Identification of fecal microbiome signatures associated with familial longevity and candidate metabolites for healthy aging.

Gong J, Liu S, Wang S, Ruan H, Mou Q, Fan P Aging Cell. 2023; 22(6):e13848.

PMID: 37132117 PMC: 10265179. DOI: 10.1111/acel.13848.

References

Twitchell W, Brown S, Mackie K . Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. J Neurophysiol. 1997; 78(1):43-50. DOI: 10.1152/jn.1997.78.1.43. View

Zhou R, Yang G, Shi Y . Dominant negative effect of the loss-of-function γ-secretase mutants on the wild-type enzyme through heterooligomerization. Proc Natl Acad Sci U S A. 2017; 114(48):12731-12736. PMC: 5715776. DOI: 10.1073/pnas.1713605114. View

Yoshida H, Hastie C, McLauchlan H, Cohen P, Goedert M . Phosphorylation of microtubule-associated protein tau by isoforms of c-Jun N-terminal kinase (JNK). J Neurochem. 2004; 90(2):352-8. DOI: 10.1111/j.1471-4159.2004.02479.x. View

Szabo G, Lenkey N, Holderith N, Andrasi T, Nusser Z, Hajos N . Presynaptic calcium channel inhibition underlies CB₁ cannabinoid receptor-mediated suppression of GABA release. J Neurosci. 2014; 34(23):7958-63. PMC: 6608264. DOI: 10.1523/JNEUROSCI.0247-14.2014. View

Lu H, Hou G, Zhang Y, Dai Y, Zhao H . c-Jun transactivates Puma gene expression to promote osteoarthritis. Mol Med Rep. 2014; 9(5):1606-12. DOI: 10.3892/mmr.2014.1981. View

Pap P, Koszeghy A, Szucs G, Rusznak Z . Cytoplasmic Ca(2+) concentration changes evoked by cholinergic stimulation in primary astrocyte cultures prepared from the rat cochlear nucleus. Hear Res. 2009; 255(1-2):73-83. DOI: 10.1016/j.heares.2009.05.006. View

Lopera F, Ardilla A, Martinez A, Madrigal L, Arango-Viana J, Lemere C . Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation. JAMA. 1997; 277(10):793-9. View

Fuller J, Cronin-Golomb A, Gatchel J, Norton D, Guzman-Velez E, Jacobs H . Biological and Cognitive Markers of Presenilin1 E280A Autosomal Dominant Alzheimer's Disease: A Comprehensive Review of the Colombian Kindred. J Prev Alzheimers Dis. 2019; 6(2):112-120. PMC: 6925534. DOI: 10.14283/jpad.2019.6. View

Bonini S, Premoli M, Tambaro S, Kumar A, Maccarinelli G, Memo M . Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history. J Ethnopharmacol. 2018; 227:300-315. DOI: 10.1016/j.jep.2018.09.004. View

10.

Lei M, Xu H, Li Z, Wang Z, OMalley T, Zhang D . Soluble Aβ oligomers impair hippocampal LTP by disrupting glutamatergic/GABAergic balance. Neurobiol Dis. 2015; 85:111-121. PMC: 4778388. DOI: 10.1016/j.nbd.2015.10.019. View

11.

Liu Q, Kawai H, Berg D . beta -Amyloid peptide blocks the response of alpha 7-containing nicotinic receptors on hippocampal neurons. Proc Natl Acad Sci U S A. 2001; 98(8):4734-9. PMC: 31903. DOI: 10.1073/pnas.081553598. View

12.

Currais A, Quehenberger O, Armando A, Daugherty D, Maher P, Schubert D . Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids. NPJ Aging Mech Dis. 2017; 2:16012. PMC: 5514994. DOI: 10.1038/npjamd.2016.12. View

13.

Sun L, Zhou R, Yang G, Shi Y . Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of Aβ42 and Aβ40 peptides by γ-secretase. Proc Natl Acad Sci U S A. 2016; 114(4):E476-E485. PMC: 5278480. DOI: 10.1073/pnas.1618657114. View

14.

Kinumi T, Kimata J, Taira T, Ariga H, Niki E . Cysteine-106 of DJ-1 is the most sensitive cysteine residue to hydrogen peroxide-mediated oxidation in vivo in human umbilical vein endothelial cells. Biochem Biophys Res Commun. 2004; 317(3):722-8. DOI: 10.1016/j.bbrc.2004.03.110. View

15.

Benek O, Korabecny J, Soukup O . A Perspective on Multi-target Drugs for Alzheimer's Disease. Trends Pharmacol Sci. 2020; 41(7):434-445. DOI: 10.1016/j.tips.2020.04.008. View

16.

Butt C, Alptekin A, Shippenberg T, Oz M . Endogenous cannabinoid anandamide inhibits nicotinic acetylcholine receptor function in mouse thalamic synaptosomes. J Neurochem. 2008; 105(4):1235-43. DOI: 10.1111/j.1471-4159.2008.05225.x. View

17.

Anandatheerthavarada H, Biswas G, Robin M, Avadhani N . Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells. J Cell Biol. 2003; 161(1):41-54. PMC: 2172865. DOI: 10.1083/jcb.200207030. View

18.

Soto-Mercado V, Mendivil-Perez M, Velez-Pardo C, Lopera F, Jimenez-Del-Rio M . Cholinergic-like neurons carrying PSEN1 E280A mutation from familial Alzheimer's disease reveal intraneuronal sAPPβ fragments accumulation, hyperphosphorylation of TAU, oxidative stress, apoptosis and Ca2+ dysregulation: Therapeutic implications. PLoS One. 2020; 15(5):e0221669. PMC: 7241743. DOI: 10.1371/journal.pone.0221669. View

19.

Schubert D, Kepchia D, Liang Z, Dargusch R, Goldberg J, Maher P . Efficacy of Cannabinoids in a Pre-Clinical Drug-Screening Platform for Alzheimer's Disease. Mol Neurobiol. 2019; 56(11):7719-7730. PMC: 6815693. DOI: 10.1007/s12035-019-1637-8. View

20.

Esposito G, De Filippis D, Carnuccio R, Izzo A, Iuvone T . The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt/beta-catenin pathway rescue in PC12 cells. J Mol Med (Berl). 2006; 84(3):253-8. DOI: 10.1007/s00109-005-0025-1. View